testosterone undecanoate has been researched along with Weight Loss in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Doros, G; Haider, A; Haider, KS; Saad, F | 1 |
| Doros, G; Haider, A; Saad, F; Traish, A | 1 |
| Carbone, MD; De Pergola, G; Giagulli, VA; Guastamacchia, E; Licchelli, B; Ramunni, MI; Sabbà, C; Triggiani, V | 1 |
| Doros, G; Haider, A; Haider, KS; Rosano, GM; Saad, F; Yassin, A | 1 |
| Cameron, ID; Chapman, I; Hunter, P; Lange, K; Naganathan, V; Piantadosi, C; Rockwood, K; Theou, O; Visvanathan, R; Wijeyaratne, L | 1 |
| Kalinchenko, SY; Tishova, Y | 1 |
1 trial(s) available for testosterone undecanoate and Weight Loss
| Article | Year |
|---|---|
Can an Intervention with Testosterone and Nutritional Supplement Improve the Frailty Level of Under-Nourished Older People?
Topics: Aged; Androgens; Dietary Supplements; Energy Intake; Exercise; Fatigue; Female; Frail Elderly; Hand Strength; Humans; Male; Malnutrition; New South Wales; South Australia; Testosterone; Treatment Outcome; Victoria; Walk Test; Weight Loss | 2016 |
5 other study(ies) available for testosterone undecanoate and Weight Loss
| Article | Year |
|---|---|
Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from
Topics: Aged; Anthropometry; Blood Pressure; Cardiovascular Diseases; Humans; Hypogonadism; Injections; Lipids; Longitudinal Studies; Male; Middle Aged; Mortality; Obesity; Overweight; Registries; Testosterone; Weight Loss | 2020 |
Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss.
Topics: Adult; Aged; Body Mass Index; Follow-Up Studies; Humans; Hypogonadism; Male; Middle Aged; Prospective Studies; Testosterone; Waist Circumference; Weight Loss | 2013 |
Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Glycated Hemoglobin; Hormone Replacement Therapy; Humans; Hypoglycemic Agents; Hypogonadism; Incretins; Liraglutide; Male; Metformin; Middle Aged; Obesity; Penile Erection; Retrospective Studies; Risk Reduction Behavior; Testosterone; Time Factors; Treatment Outcome; Weight Loss | 2015 |
Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Germany; Health Status; Heart Rate; Hormone Replacement Therapy; Humans; Hypogonadism; Lipids; Male; Middle Aged; Recurrence; Registries; Secondary Prevention; Testosterone; Time Factors; Treatment Outcome; Waist Circumference; Weight Loss | 2016 |
Breaking the vicious circle of obesity: the metabolic syndrome and low testosterone by administration of testosterone to a young man with morbid obesity.
Topics: Adult; Androgens; Humans; Male; Metabolic Syndrome; Obesity, Morbid; Testosterone; Waist Circumference; Weight Loss | 2009 |